Study IDs predictors of death, transplant in pediatric hypertrophic cardiomyopathy

09/4/2013 | HealthDay News

U.S. researchers followed almost 1,100 children with hypertrophic cardiomyopathy for 19 years and found that those with inherited metabolic problems or a combination of hypertrophic cardiomyopathy and other cardiomyopathy phenotypes had worse outcomes. Congestive heart failure, diagnosis at a younger age, lower weight, and symptoms of abnormal left ventricle structure or function were linked to increased odds of dying. Patients with two or more of these risk factors were at greater risk of dying or heart transplant, according to the study presented at the European Society of Cardiology meeting and published in The Lancet.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD